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To elucidate the role of a modern diagnostic laboratory in the management of diabetes mellitus
Available literature on local and international studies on the role of the laboratory in the
management of diabetes mellitus
Preclinical diagnosis of diabetes mellitus, good monitoring of short, medium and long-term
glycaemic control necessary to avoid diabetic complications in poor resource settings are now possible with
modern diagnostic laboratories.
Creating the required awareness on the roles of a diagnostic laboratory in the management of
diabetes mellitus is needed now more than ever before in resource poor nations otherwise the success achieved
by the developed world where diabetic patients become insulin independent after islet cell transplant with
glucocorticoid free immunosuppression cannot be attained in the near future.
: Diabetes mellitus, test utilizations (
INTRODUCTION
Diabetes mellitus is a major health problem both in
the developed and the developing countries
its prevalence being on the increase . The disease has
been known to mankind for over 2000 years but
until recently, this global epidemic, recognized
increasingly as a major health problem in the
developing countries was made to look like a disease
of Europe and the Americas . Poverty has made
laboratories in this environment incapable of
keeping pace with modern laboratory management
of diabetes mellitus leading to underutilization of
laboratory facilities where available, and making
diagnosis of diabetes at the preclinical stage hardly
possible . The debt forgiveness of poor countries,
including Nigeria, the sustained high price of crude
oil and the global fight against corruption and bad
governance are expected to raise the socioeconomic
status in the poor resource countries leading to
sedentary lifestyle and obesity known to increase the
rising prevalence of type 2 diabetes mellitus. This
will mean that the current services provided to
people with diabetes will need to be revised in the
now poor resource countries. Therefore, the review










the modern management of diabetes mellitus at
preclinical and clinical levels of the disease, a
necessary requirement at stemming the challenges of
this global epidemic.
Laboratory medicine, which is the scientific base for
the practice of 21 century medicine, differentiates
modern medicine from traditional medicine. While
the roles of clinical laboratories in the management of
diabetes mellitus are fully achievable in the
developed countries, the same cannot be said for the
developing economies. Amongst the roles of clinical
laboratories in the management of diabetes mellitus
are:
Preclinical diagnosis of diabetes mellitus
Preclinical diagnosis detects potential diabetics
before the subject presents with clinical symptoms of
diabetes mellitus. Waiting for the clinical features like
polyuria, polydipsia, polyphagia, weight loss or the
laboratory diagnosis of clinical diabetes mellitus like
consecutive fasting hyperglycaemia above 7.0
mmol/l or unequivocal hyperglycaemia with the
above symptoms delay the detection of potential
diabetics. Delayed detection of diabetes generally
promotes diabetic complication (s) known to raise the
cost of management even in poor resource settings
where diabetic patients can hardly afford the cost of
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of diabetic management. Markers of immune
destruction of tissues or hormone responsible for the
metabolism of glucose like islet cell auto antibodies,
antibodies to insulin or its receptors, and antibodies
to glutamic acid decarboxylase are present in about
90% of individuals with type 1 diabetes mellitus
when fasting hyperglycaemia is initially detected .
Fasting hyperglycaemia diagnosing diabetes
mellitus also occurs long time before the clinical
fea tures of d iabe tes mel l i tus , as only
hyperglycaemia that has exceeded the renal
threshold presents with poyuria which leads to the
polydipsia, the early clinical presentations of
diabetes mellitus. Conscious of the delay and the
need to avoid the attendant complications arising
there from, the American Diabetes Association has
called for the screening of immune related markers
in first-degree relatives of individuals with type 1
diabetes for about a decade now. To move in pace
with the global trend, it is time to create the required
awareness for the early diagnosis of diabetes
mellitus and monitor the introduction of appropriate
management to avoid complications.
Immunological markers can be detected early in the
laboratories of developed countries, sometimes
about a decade before the manifestation of clinical
diabetes mellitus. Immunological markers of
interest for the preclinical diagnosis of diabetes
mellitus include:
An antibody that slowly destroys
the ß cells of the islet of Langerhans,which produces
and secretes insulin. Depending on the severity and
duration, the body insulin may be too low to maintain
metabolic functions, leading to diabetes mellitus
with the potential of developing complications if not
properly controlled on time.
destroys already formed
insulin, which leads to insulin inactivity.
destroys the insulin
receptor, which prevents the receptor-insulin
binding required for insulin activity.
is also an
immunological marker for preclinical diagnosis of
diabetes mellitus.
A population or an individual at risk of diabetes
mellitus is screened for the disease. Subjects not at
the risk of the disease could be screened periodically
during medical check up. Screening has increased
the rate of self reported diabetes mellitus in the
developed countries, which has made diagnosis of







Insulin receptor Auto antibody
Anti glutamic acid decarboxylase
Timely detection of immunological
markers in potential diabetics
2. Screening patients at risk of diabetes
mellitus
.
developing countries where diagnosis is delayed to
the extent of patients presenting for the first time not
only with symptom but also with lethal diabetic
complication . Women with poor obstetric historyor
first-degree relative of diabetics need to be screened
for gestational diabetes mellitus using 50g glucose
dose irrespective of the time of last meal during the
18 to 24 week of gestation. Screening for
gestational diabetes mellitus is important as early
detection and strict glycaemic control protect both
the foetus and the mother from complications.
Therefore, obstetricians and chemical pathologists in
developing countries need to develop the teamwork
approach for the early detection and management of
good glycaemic control to avoid diabetic
complication during pregnancy. Access to point of
care diabetic control facilities; search for diabetes
mellitus during pregnancy and enlightenment of
potential mothers for the need for screening are also
recommended.
Diabetes mellitus, being a chronic disease, demands
for timely and precise diagnosis as mislabeling a
patient has grave consequences. Diagnosis of clinical
diabetes should not be based on a single
hyperglycaemic glucose result in an
asymptomatic individual, but two consecutive
results in the diagnostic ranges or an unequivocal
hyperglycaemia in a symptomatic subject.
Hyperglycaemia detected under acute infective
condition, traumatic or stressful conditions like
circulatory disorders are not conclusively diagnostic
of diabetes mellitus.
The following diagnostic criteria are required for
diagnosing the disease:
i. Classical symptoms of diabetes mellitus with
casual plasma glucose level of ≥11.1 Casual
glucose refers to the blood glucose estimated
irrespective of the time of the last meal.
ii. Fasting plasma glucose equal to or greater than
7.0 mmol/l on more than one occasion or
iii. Two hour non-gestational oral glucose tolerance
test that is equal or greater than 11.1 mmol/l on more
than one occasion.
Values greater than the normal fasting blood glucose
but lower than the diagnostic levels for diabetes are
considered impaired fasting glucose, which is
defined as fasting plasma glucose greater than the
upper reference limit of fasting plasma glucose but
less than 7.0 mmol/l, or and 2 hour OGTT between
7.8 and 11.0 mmol/l. Such individuals need to be





2. Clinical diagnosis of diabetes mellitus
4. Monitoring diabetes mellitus
mmol/l.
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Monitoring the success of transplant of pancreas or
of the transplant of islet cells of Langerhans
involves the estimation of insulin and or C peptide.
Fasting plasma glucose monitors short-term
glycaemic control while intermediate and long term
control are monitored by fructosamine and glycated
haemoglobulin respectively. Complications of
diabetes mellitus and those of therapy are also
monitored by the clinical laboratory.
Clinical laboratory is very essential in the
classification of diabetes mellitus, as the disease is
no longer classified based on the therapeutic needs
but on its aetiopathologenesis.
Type 1 diabetes mellitus. This encompasses the
majority of cases, which are primarily due to
pancreatic islet beta- cell destruction and are prone
to ketosis. Laboratory also has a role in
differentiating between autoimmune and idiopathic
origin of this class of disease.
Type 2 diabetes mellitus. This class results from
relative deficiency in insulin secretion early in the
disease, usually with insulin resistance. Later in the
disease, absolute insulin deficiency results. It has
been reported that insulin resistance is the primary
defect, preceding the derangement in insulin
secretion and clinical diabetes by as much as 20
years
Impaired fasting glycaemia, which classify
individuals with fasting blood glucose values above
normal values but below those diagnostic of diabetes
Gestational diabetes mellitus, which also includes
gestational impaired glucose tolerance. Close
monitoring of both maternal and fetal clinical
conditions need to be maintained by teamwork
approach consisting of laboratory physicians with
the other team members. Monitoring of maternal
urinary glucose is not useful in the management of
gestational diabetes mellitus, therefore; clinicians
should desist from such practices.
Other specific types
Diseases of the exocrine pancreas
Genetic defects in insulin action
Genetic defects of the beta-cell function
Infections
Drug or Chemical induced
Genetic syndromes associated with diabetes
Uncommon forms of immune mediated
diabetes
Other endocrine disorders associated with
hyperglycaemia
Malnutrition related diabetes mellitus and impaired
glucose tolerance tesclassification as impaired
glucose tolerance is ts are now deleted from the
















observed in any hyperglycemic disorder.
Classification is needed for the proper choice of
therapy, anticipation of disease complications, its
transmission and prognosis. Chemical pathology
laboratory is needed to achieve these goals.
i. Acute management of diabetes requires the
estimation of blood glucose concentration for short-
term glycaemic control. Urine glucose is also
estimated, a procedure that can be done by the patient
even in a village setting. Negative urine glucose has
the disadvantages of not differentiating between
hypoglycaemia and normoglycaemia or even
hyperglycaemia below the renal threshold. More so,
by the time glycosuria is detected, the glycaemic
control is already poor, a possibility for the
development of diabetic complication.
ii. Measurement of ketone bodies in plasma and
urine detects disease complication early enough for
prompt management
iii. Estimation of the acid base status is useful in
type 1 diabetes mellitus where diabetic ketoacidosis
is a common and dangerous complication.
iv. Analysis of serum electrolytes to elucidate fluid
and electrolyte derangement and guide its
management.
Determination of plasma osmolarity detects type 2
diabetics at risk of developing hyperosmolar non-
ketotic coma and guides management early enough
for better outcome
i. Determination of plasma glucose remains
popular and gives the understanding of current
level of blood glucose at the time of blood
sampling.
ii. Determination of glycated proteins for the
determination of short and long term glycaemic
control.
iii. Determination of urinary proteins detects renal
comp l i ca t i ons o f the d i sease on t ime
iv. Tests for renal function to establish or otherwise
renal complication of the disease that are common in
poor resource settings
v. Tests for lipid profile to detect the metabolic
syndrome X and other lipid derangements known to
be associated with this disease.
vi. Tests for the success of islets or pancreatic
transplants as indicated earlier.
vii. Checking for complications of diabetes
mellitus
Diabetic complication cuts across medical
specializations including Chemical pathology,
Nephrology, Neurology, Medical microbiology,
Opthalmology, general and vascular surgery among
6.Acute management of diabetes mellitus
7. Chronic management of diabetes mellitus
COMPLICATIONS OFDIABETES MELLIUS
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others. Following the demonstration of a
correlationbetween blood glucose concentrations
and the development of long term complications of
diabetes, more emphasis is mounted on
monitoring glycaemic control to avoid diabetic
complications.
. Severe ketoacidosis is
responsible for most deaths among patients with
insulin requiring diabetes .Acommon complication
of diabetes mellitus occurring in insulin dependent
diabetes mellitus when insulin is insufficient leading
to metabolism of fat through ß-oxidation for
alternative source of energy producing excess
ketone bodies. Maintenance of good short and long
term glycaemic control prevents diabetic
ketoacidosis complicating diabetes mellitus. Severe
cases of diabetic ketoacidosis are associated with
coma.
. It is a
complication of diabetes mellitus that occurs when
the insulin activity is enough only for fat metabolism
but not to maintain glycaemic control thereby
leading to hyperglycaemia and hyperosmolarlity
without ketosis.
This is a diabetic complication
that occurs when there is overzealous theraphy for
diabetes mellitus or appropriate drug ingestion
without feeding. Tight glycaemic control in insulin
dependent diabetics may be associated with a
hypoglycaemic feature once a week.
. Glycosylation of low
density lipoprotein prevents its uptake and clearance
from blood by receptors and catabolizing enzymes .
Glycosulation of proteins include
immunoglobulins, which causes dysfunction of
humoral immunity leading to infection among other
causes
. This complication is encountered
by about one third of diabetic patients. The retina
and the lens are damaged through the polyol
pathways dysfunction which leads to excess
accumulation of sorbitol that damages optic
tissues .
is more likely to affect long-
standing diabetics and those with sustained poor
glycaemic control. Neuropathy causes: numbness,
urinary bladder dysfunction, paralysis, prickling,
tingling, burning aching or sharp jabs of needle like
pain is a complication of diabetes occurring in two
to thirty percent of diabetics depending on the
prevalence of complications in the study location.
Painful sensory symptoms and anaesthetic foot






















which simple screening has been shown to reduce
amputation rates significantly. Diabetes is
preventable even in high risk individuals when the
clinical laboratory takes up its appropriate roles in
the management of diabetes mellitus.
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